Literature DB >> 12894247

Control of gut differentiation and intestinal-type gastric carcinogenesis.

Yasuhito Yuasa1.   

Abstract

Gastric cancer is one of the world's most common cancers. Its carcinogenic pathway is mainly associated with Helicobacter pylori infection, subsequent inflammation and tissue regeneration. During the regeneration process, cells deviate from the normal pathway of gastric differentiation to an 'intestinal phenotype', which is thought to be precancerous and associated with the intestinal type of gastric cancer. Inappropriate activation of intestine-specific transcription factors could contribute to the occurrence of the intestinal-type cancer of the stomach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894247     DOI: 10.1038/nrc1141

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  122 in total

1.  Programmed cell death 6 (PDCD6) as a prognostic marker for gastric cancers.

Authors:  Jung Hwan Yoon; Yoo Jin Choi; Sung Geun Kim; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Tumour Biol       Date:  2011-12-13

Review 2.  EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors:  Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

Review 3.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

4.  Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins.

Authors:  Mami Mihara; Yukinari Yoshida; Tetsuya Tsukamoto; Ken-ichi Inada; Yukihiro Nakanishi; Yukiko Yagi; Kohzoh Imai; Takashi Sugimura; Masae Tatematsu; Toshikazu Ushijima
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

5.  Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.

Authors:  Jun Nakamura; Yoshihiko Kitajima; Keita Kai; Kazuyoshi Hashiguchi; Masatsugu Hiraki; Hirokazu Noshiro; Kohji Miyazaki
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

6.  Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon.

Authors:  Masato Suzuki; Kotaro Kiga; Dangeruta Kersulyte; Jaime Cok; Catherine C Hooper; Hitomi Mimuro; Takahito Sanada; Shiho Suzuki; Masaaki Oyama; Hiroko Kozuka-Hata; Shigeru Kamiya; Quan-Ming Zou; Robert H Gilman; Douglas E Berg; Chihiro Sasakawa
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

7.  Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma.

Authors:  Artit Jinawath; Yoshimitsu Akiyama; Yasuhito Yuasa; Chawalit Pairojkul
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-23       Impact factor: 4.553

Review 8.  Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases.

Authors:  Motohiro Kobayashi; Hitomi Hoshino; Kenichi Suzawa; Yasuhiro Sakai; Jun Nakayama; Minoru Fukuda
Journal:  Semin Immunopathol       Date:  2012-05-10       Impact factor: 9.623

9.  Expression of early growth response gene-1 in precancerous lesions of gastric cancer.

Authors:  Seon-Young Park; Ji-Young Kim; Su-Mi Lee; Jin Ook Chung; Kyung-Hwa Lee; Chung-Hwan Jun; Chang-Hwan Park; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew; Young-Do Jung; Yong Han Lee
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

10.  A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression.

Authors:  Hyoungseok Ju; Byungho Lim; Minjin Kim; Yong Sung Kim; Woo Ho Kim; Chunhwa Ihm; Seung-Moo Noh; Dong Soo Han; Hang-Jong Yu; Bo Youl Choi; Changwon Kang
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.